Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Morgan Stanley analyst Sean Laaman maintained a Sell rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$258.00. The company’s shares closed last Friday at $205.54.
LONE TREE, Colo., June 2, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results